trending Market Intelligence /marketintelligence/en/news-insights/trending/moeN6JqNZ3y2dHaOus87dg2 content esgSubNav
In This List

Medtronic raises fiscal Q3'20 cash dividend by 8%

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Medtronic raises fiscal Q3'20 cash dividend by 8%

Medtronic PLC's board approved a dividend of 54 cents per ordinary share for the third quarter of the fiscal year 2020.

The dividend is 8% higher than the prior-year period and is payable Jan. 17, 2020, to shareholders of record as of Dec. 27.

Dublin-based Medtronic sells device-based medical treatments focused on cardiovascular disease, regenerative therapies and diabetes to hospitals and physicians.